Activating and inhibitory Fcγ receptors in rheumatoid arthritis: From treatment to targeted therapies

3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Fcγ receptors (FcγRs) bind the constant Fc region of IgG molecules. IgG/antigen-containing immune complexes elicit a variety of effector functions in cells that express activating FcγRs. Because activating FcγRs are present on cells from the innate immune system, such as dendritic cells, monocytes/macrophages and granulocytes, these IgG receptors form a crucial link between the innate and the acquired immune systems. Recently, the ability to detect the inhibitory FcγRIIb on cells has indicated an imbalance between activating and inhibitory FcγRs in rheumatoid arthritis. This progress offers an opportunity to study modulation of FcγR balance and could stimulate development of FcγR-directed immunotherapy. © 2007 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Van Roon, J. A. G. (2007, August 20). Activating and inhibitory Fcγ receptors in rheumatoid arthritis: From treatment to targeted therapies. Arthritis Research and Therapy. https://doi.org/10.1186/ar2224

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free